Physician

Amin Esfahani, M.D.

According to 2025 Medicare claims, Amin Esfahani, M.D. (NPI: 1407261217) practices dermatology in the Modesto, CA market, with the plurality of this provider's patient population coming from Stanislaus, CA. This provider's primary affiliated billing organization is AMIN ESFAHANI M.D. CORPORATION (NPI: 1689492209; TIN: 994399955) and primary practice location at 95361-3529.

Esfahani's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,071 traditional Medicare patients, billed 7,559 HCPCS/CPT codes, and received $326,966 in Medicare payments. The top billing code was 11102 (Biopsy of related skin growth, first growth). Part D data shows 1,313 prescription claims across 514 beneficiaries totaling $717,941 in drug costs, led by Skyrizi Pen (Risankizumab-Rzaa). Open Payments data shows 40 records totaling $1,038. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $16,505 to $326,966. Similarly, Part D prescription costs have risen steadily, from $1,524 to $717,941. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	114	272	$16,505
2019	388	1,966	$86,942
2020	468	2,283	$91,151
2021	494	2,745	$129,234
2022	933	6,592	$406,599
2023	959	8,357	$382,443
2024	1,071	7,559	$326,966

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	20	$1,524
2016	29	54	$9,108
2017	22	42	$5,391
2018	55	94	$4,527
2019	153	335	$23,620
2020	172	383	$47,078
2021	219	481	$248,669
2022	342	828	$294,751
2023	472	1,182	$358,182
2024	514	1,313	$717,941

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
11102	Biopsy of related skin growth, first growth	363	418	$76
99203	New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more	295	295	$68
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	772	1,180	$64
17000	Destruction of precancer skin growth, 1 growth	632	888	$43
17003	Destruction of precancer skin growth, 2-14 growths	532	3,575	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Skyrizi Pen	Risankizumab-Rzaa	19	1,484	$409,475
Otezla	Apremilast	33	990	$156,260
Dupixent Pen	Dupilumab	29	812	$106,015
Betamethasone Dipropionate	Betamethasone Dipropionate	87	2,319	$3,794
Ivermectin	Ivermectin	16	480	$3,543

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	40	$1,038	Janssen Biotech, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Amin Esfahani, M.D.?

Tedicare shows public-source Medicare data for Amin Esfahani, M.D. (NPI 1407261217), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Amin Esfahani, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Amin Esfahani, M.D.?

Amin Esfahani, M.D. is linked to AMIN ESFAHANI M.D. CORPORATION (billing NPI 1689492209) in the available physician profile data.

Does Amin Esfahani, M.D. have Open Payments data?

Amin Esfahani, M.D. has 40 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.